Preview

Siberian Journal of Clinical and Experimental Medicine

Advanced search

The role of obstructive sleep apnea biomarkers in assessment of cardiovascular risk

https://doi.org/10.29001/2073-8552-2019-34-4-49-54

Abstract

The review article presents a contemporary view on biomarkers of obstructive sleep apnea syndrome (OSAS) and their role in the assessment of cardiovascular risk. The cause-effect relationships between cardiovascular diseases and OSAS are still poorly understood. The assessment of an independent impact of OSAS on the cardiovascular risk in various subgroups of patients is required. It should be taken into account that one may rely not only on specific markers, but also on available routine laboratory tests in order to diagnose OSAS and evaluate the effectiveness of its treatment.

About the Authors

L. G. Evlampieva
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Larisa G. Evlampieva - Cand. Sci. (Med.), Junior Research Scientist, Laboratory of Instrumental Diagnostics, Scientific Division of Instrumental Research Methods.

111, Melnikaite str., Tyumen, 625026



E. I. Yaroslavskaya
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Elena I. Yaroslavskaya - Dr. Sci. (Med.), Acting Director of the Scientific Division of Instrumental Research Methods.

111, Melnikaite str., Tyumen, 625026



K. V. Aksenova
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Kristina V. Aksenova – Cardiologist.

111, Melnikaite str., Tyumen, 625026



O. I. Sergeichik
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Oksana I. Sergeichik - Research Scientist, Laboratorv of Instrumental Diagnostics, Scientific Division of Instrumental Research Methods.

111, Melnikaite str., Tyumen, 625026



References

1. Shamsheva D.S. Obstructive sleep apnea: modern state of the problem. J. Health Care. 2014;1:14-16 (In Russ.).

2. Aurora R.N., Collop N.A., Jacobowitz O., Thomas S.M., Quan S.F., Ar-onsky A.J. Quality measures for the care of adult patients with obstructive sleep apnea. J. din. Sleep Med. 2015;11(3):357-383. DOI: 10.5664/jcsm.4556.

3. American Academy of Sleep Medicine: International classification of sleep disorders, 2nd edition: Diagnostic and coding manual. Illinois: Westchester; 2005.

4. Koren D., Dumin V., Gozal D. Role of sleep quality in the metabolic syndrome. J. Diabetes Metab. Syndr. Obes. 2016;9:281-310. DOI: 10.2147/DMSO.S95120.

5. Goncharov A.P., Volov N.A., Shaydyuk O.Y Obstructive sleep apnea syndrome in patients with functional class IV effort angina. Russian Journal of Cardiology. 2010;(1):18-23 (In Russ.). DOI: 10.15829/1560-4071-2010-1-18-23.

6. Mitkovskaya N.P., Grigorenko E.A., Lazar E.A., Pinchuk A.F. Clinical ^ara^^stics of оbstructive deep аpnea as a risk factor of coronary heart disease. J. Military Medicine. 2013;1:127-133 (In Russ.).

7. Xie C., Zhu R., Tian Ya., Wang K. Association of obstructive sleep ap-noea with the risk of vascular outcomes and all-cause mortality: a meta-analysis. BMJ Open. 2017;7(12):e013983. DOI: 10.1136/bmjop-en-2016-013983.

8. Vorobyeva E.N., Vorobyev R.I., Sharlaeva E.A., Fomicheva M.L., Sokolova G.G., Kazizaeva A.S. et al. Endothelial dysfunction in cardiovascular diseases: risk factors, methods of diagnosnic, and correction. Acta Biolog^a Sibirica. 2016;2(1):21-40 (In Russ.). DOI:10.14258/abs.v2i1-4.923.

9. Van den Heuvel M., Sorop O., Musters P.J., van Domburg R.T., Gale-ma T.W., Duncker D.J. et al. Peripheral arterial tonometry cannot detect patients at low risk of coronary artery disease. Neth. Heart J. 2015;23(10):468-474. DOI: 10.1007/s12471-015-0715-4.

10. Ryan S., Taylor C.T., McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005;112:2660-2667. DOI: 10.1161/CIRCULA-TIONAHA.105.556746.

11. Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F. et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122(4):352-360. DOI: 10.1161/CIRCULATION-AHA.109.901801.

12. Hedetoft M., Olsen N.V. Evaluation of endothelial function by peripheral arterial tonometry and relation with the nitric oxide pathway. Nitric. Oxide. 2014;42:1-8. DOI: 10.1016/j.niox.2014.07.003.

13. Wang J., Yu. W., Gao M., Zhang F., Gu C., Yu Y. et al. Impact of obstructive sleep apnea syndrome on endothelial function, arterial stiffening, and serum inflammatory markers: an updated meta-analysis and metaregression of 18 studies. J. Am. Heart Assoc. 2015;4(11):e002454. DOI:10.1161/JAHA.115.002454.

14. Wu C.F., Liu P.Y., Wu T.J., Hung Y, Yang S.P., Lin G.M. Therapeutic modification of arterial stiffness: An update and comprehensive review. World J. Cardiol. 2015;7(11):742-753. DOI: 10.4330/wjc.v7.i11.742.

15. Oleynikov V.E., Burko N.V., Salamova L.I., Ziboreva K.A. Effect of obstructive sleep apnea syndrome on arterial stiffness in patients at high cardiovascular risk. Ration Pharmacother Cardiol. 2016;12(3):272-276 (In Russ.). DOI: 10.20996/1819-6446-2016-12-3-272-276.

16. Chien M.Y, Lee P, Tsai YF., Yang P.C., Wu YT. C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea. Sleep Breath. 2012;16(3):629-637. DOI: 10.1007/s11325-011-0549-2.

17. Guven S.F., Turkkani M.H., Ciftci B., Ciftci T.U., Erdogan Y The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath. 2012;16(1):217-221. DOI: 10.1007/s11325-011-0492-2.

18. Ning Y, Zhang T.S., Wen W.W., Li K., Yang Y.X., Qjn YW. et al. Effects of continuous positive airway pressure on cardiovascular biomarkers in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. Sleep Breath. 2019;23(1):77-86. DOI: 10.1007/s11325-018-1662-2.

19. Kim E.S., Mo E.Y, Moon S.D., Han J.H. Mean рlatelet volume is closely associated with serum glucose level but not with arterial stiffness and carotid atherosclerosis in patients with type 2 diabetes. The Journal of dinical Еndocrinology and Мetabolism. 2015;100(9):3502-3508. DOI: 10.1210/JC.2015-1540.

20. Chen L.D., Lin L., Lin X.J., Ou YW., Wu Z., Ye YM. et al. Effect of continuous positive airway pressure on carotid intima-media thickness in patients with obstructive sleep apnea: A meta-analysis. PLоS ONE. 2017;12(9):e0184293. DOI: 10.1371/journal.pone.0184293.

21. Zhang D., Luo J., Qiao Y, Xiao Y, Huang R., Zhong X. Measurement of exhaled nitric oxide concentration in patients with obstructive sleep apnea. A meta-analysis. Medicine (Baltimore). 2017;96(12):e6429. DOI: 10.1097/MD.0000000000006429.

22. Liu J., Li Z., Liu Z., Zhu F., Li W., Jiang H. et al. Exhaled nitric oxide from the central airway and alveoli in OSAHS patients: the potential correlations and clinical implications. Sleep Breath. 2016;20(1):145-154. DOI: 10.1007/s11325-015-1198-7.

23. Tichanon P, Wilaiwan K., Sopida S. Orapin P, Watchara B., Banjamas I. Effect of continuous positive airway pressure on airway inflammation and oxidative stress in patients with obstructive sleep apnea. Can. Re-spir. J. 2016:3107324. DOI: 10.1155/2016/3107324.

24. Huang Z.W., Ouyang W., Zhang L.J., Li H., Ye YM., Lin X.J. et al. Association of continuous positive airway pressure with F2-isoprostanes in adults with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2019;7. DOI: 10.1007/s11325-019-01795-6.

25. Vasilyev A.V., Sharanova N.E., Kulakova S.N. Nutrimetabolomics-the new stage of biochemistry of nutrition. The role nutrilipidomic analysis. J. Nutrition Issues. 2014;83(1):4-11 (In Russ.).

26. Eisele H.J., Markart P, Schulz R. Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxid. Med. Cell. Longev. 2015; 2015:608438. DOI: 10.1155/2015/608438.

27. Herasymchuk N.M. 8-isoprostane as the main marker of oxidative stress. Zaporozhye Medical J. 2018;20(6):853-859 (In Ukr.). DOI: 10.14739/2310-1210.2018.6.146780.

28. Wu M., Zhou L., Zhu D., Lai T., Chen Zh., Shen H. Hematological indices as simple, inexpensive and practical severity markers of obstructive sleep apnea syndrome: a meta-analysis. J. Thorac. Dis. 2018;10(12):6509-6521. DOI: 10.21037/jtd.2018.10.105.


Review

For citations:


Evlampieva L.G., Yaroslavskaya E.I., Aksenova K.V., Sergeichik O.I. The role of obstructive sleep apnea biomarkers in assessment of cardiovascular risk. Siberian Journal of Clinical and Experimental Medicine. 2019;34(4):49-54. (In Russ.) https://doi.org/10.29001/2073-8552-2019-34-4-49-54

Views: 637


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2713-2927 (Print)
ISSN 2713-265X (Online)